G-CSF does not worsen toxicities and efficacy of CAR-T cells in refractory/relapsed B-cell lymphoma
Abstract
No abstract available
Christophe leboeuf : Connect in order to contact the contributor
https://www.hal.inserm.fr/inserm-03925115
Submitted on : Thursday, January 5, 2023-3:11:07 PM
Last modification on : Saturday, February 11, 2023-4:00:29 AM